In Vitro Lung Model Market Size And Forecast

In Vitro Lung Model Market size was valued at USD 295.13 Billion in 2024 and is projected to reach USD 1,035.71 Billion by 2031, growing at a CAGR of 16.8% from 2024 to 2031.

An increasing focus on developing alternatives for animal testing models, and technological advancements in 3D cell culture technology are the factors expected to drive the In Vitro Lung Model Market. The Global In Vitro Lung Model Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global In Vitro Lung Model Market Definition

The lung in vitro models is defined as cell models that represent normal or diseased lung physiology. The human lungs are the delicate organ and are the main portal for entry and exit of aerosolized materials and gases. Animal testing is still the most prevalent model used to study various diseases but in order to reduce animal experimentation, a need has arisen for realistic and well-accepted in vitro alternatives. In vitro lung model can be established by culturing epithelial cells, macrophages, and dendritic cells favorable for the culture medium.

Global In Vitro Lung Model Market Overview

The growing research on lung diseases is projected to offer growth potential for the In Vitro Lung Model Market at the global level. The cases of asthma, lung cancer, and COPD have been rising across the globe at a significant speed. Thus, there is a need to study lung diseases. This is driving the global market. An increasing focus on technological advancements in 3D cell culture technology, and the development of alternatives for animal testing models are the factors expected to drive the In Vitro Lung Model Market.

Moreover, the development of new 3D in vitro models is likely to boost the market. Furthermore, factors such as applications in regenerative medicine, tissue engineering, and oncology research coupled with the increasing number of drug discovery activities are driving the overall growth of the Global In Vitro Lung Model Market. However, a shortage of skilled professionals might hamper the market growth.

Global In Vitro Lung Model Market: Segmentation Analysis

The Global In Vitro Lung Model Market is segmented on the basis of Type, Application, And Geography.

In Vitro Lung Model Market, By Type

• 2D Models• 3D Models

Based on Type, The market is bifurcated into 2D Models and 3D Models. The 2D Models segment holds the largest market share. The factors that can be attributed to the rising need for efficient lung in vitro models that mimic in vivo physiology.

In Vitro Lung Model Market, By Application

• Drug Screening• Toxicology• 3D Model Development• Others

Based on Application, The market is bifurcated into Drug Screening, Toxicology, 3D Model Development, and Others. The Drug Screening and Toxicology segment is estimated to hold the largest share. The factors that can be attributed to the flexibility and high throughput capabilities of 2D cell models. The 3D cell models provide the relevant in vivo environment and reproducibility for drug discovery and toxicology applications.

In Vitro Lung Model Market, By Geography

• North America• Europe• Asia Pacific• Rest of the world

On the basis of Regional Analysis, The Global In Vitro Lung Model Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America holds the largest market share. The flourishing research environment and abundant funding programs such as increased funds for the National Institutes of Health (NIH) and increased R&D activities by biotechnology and pharmaceutical companies will boost the market in this region.

Key Players

The “Global In Vitro Lung Model Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are TissUse, Lonza, ATCC, Mattek, Epithelix, Emulate, Insphero, Mimetas, CN Bio Innovations.

The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

Partnerships, Collaborations and Agreements

• In December 2021, Lonza, a global pioneer in cell and gene therapy, and Agilent Technologies, a market leader in life sciences analytics, diagnostics, and applied chemicals, announced cooperation. The collaboration’s goal is to create and integrate current and emerging analytical technologies into patient-scale cell therapy manufacturing workflows.

• In September 2021, BICO introduces a contract research offering for 3D bioprinting from CELLINK, MatTek, and Visikol. The three businesses have joined forces to provide consumers with the first full-service 3D biomanufacturing and in vitro analysis service of its type.

• In June 2020, Lonza and the Swedish business CELLINK have collaborated to provide a full 3-dimensional (3D) bioprinting system that aims to optimize and expand access to entire 3D cell culture operations. The solution combines CELLINK’s 3D bioprinting tools and bio-inks with Lonza’s extensive collection of human-derived primary cells and culture medium.

• In December 2019, InSphero AG announced a USD 10 million grant for their research on discovery platforms for cancer and metabolic illnesses. InSphero AG is a 3D cell-based platform creator and supplier in efficacy testing and medication discovery.

Merger and Acquisition

• In March 2021, CELLINK, a Swedish 3D bioprinter maker, has agreed to buy MatTek Corporation, an in-vitro technology expert, for $68 million.

Report Scope

Research Methodology of Market Research:

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.